* Quipt Home Medical Corp QIPT.V is expected to show a
rise in
quarterly revenue when it reports results on May 16.
* The Wilder Kentucky-based company is expected to report
a
39.1% increase in revenue to $41.084 million from $29.53 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Quipt Home Medical
Corp
is for earnings of 3 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Quipt Home
Medical Corp is $10.06, above its last closing price of $6.35.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.02 0.02 0.07 Beat 250
Jun. 30 2022 0.00 0.00 0.00 Met
Mar. 31 2022 0.00 0.03 0.14 Beat 366.7
Dec. 31 2021 -0.02 -0.01 -0.06 Missed -799.5
Sep. -0.03 -0.01 -0.04 Missed -220
30 2021
Jun. 30 2021 0.04 0.04 0.19 Beat 418.1
This summary was machine generated May 12 at 16:42 GMT. All
figures in US dollars unless otherwise stated